Evidence for efficient vertical transfer of maternal HIV-1 envelope-specific neutralizing antibodies but no association of such antibodies with reduced infant infection

Journal of Acquired Immune Deficiency Syndromes

Volumn 64, Issue 2, 2013, Pages 163-166

  Omenda, Maxwel M ^a,b   Milligan, Caitlin ^a,b   Odem Davis, Katherine ^a   Nduati, Ruth ^c   Richardson, Barbra A ^a,b   Lynch, John ^a,b   John Stewart, Grace ^b   Overbaugh, Julie ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF NAIROBI   (Kenya)

Author keywords

HIV 1 envelope; Mother to child transfer; Neutralizing antibodies

Indexed keywords

NEUTRALIZING ANTIBODY; VIRUS DNA;

ANTIBODY BLOOD LEVEL; BREAST FEEDING; BREAST MILK; CONFERENCE PAPER; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MAJOR CLINICAL STUDY; MATERNAL PLASMA; MOTHER; NEWBORN INFECTION; PLACENTAL TRANSFER; PRIORITY JOURNAL; VIRUS ENVELOPE; VIRUS LOAD;

ANTIBODIES, NEUTRALIZING; ANTIBODY SPECIFICITY; BREAST FEEDING; ENV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; FEMALE; HIV ANTIBODIES; HIV INFECTIONS; HIV-1; HUMANS; IMMUNITY, MATERNALLY-ACQUIRED; INFANT; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; KENYA; NEUTRALIZATION TESTS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 84885320438     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31829f6e41     Document Type: Conference Paper

References (15)

1. Nduati R, John G, Mbori-Ngacha D, et al. Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial. JAMA. 2000;283: 1167-1174.
2. Dickover R, Garratty E, Yusim K, et al. Role of maternal autologous neutralizing antibody in selective perinatal transmission of human immunodeficiency virus type 1 escape variants. J Virol. 2006;80: 6525-6533.
3. Lathey JL, Tsou J, Brinker K, et al. Lack of autologous neutralizing antibody to human immunodeficiency virus type 1 (HIV-1) and macrophage tropism are associated with mother-to-infant transmission. J Infect Dis. 1999;180: 344-350.
4. Scarlatti G, Albert J, Rossi P, et al. Mother-to-child transmission of human immunodeficiency virus type 1: correlation with neutralizing antibodies against primary isolates. J Infect Dis. 1993;168: 207-210.
5. Samleerat T, Thenin S, Jourdain G, et al. Maternal neutralizing antibodies against a CRF01-AE primary isolate are associated with a low rate of intrapartum HIV-1 transmission. Virology. 2009;387: 388-394.
6. Husson RN, Lan Y, Kojima E, et al. Vertical transmission of human immunodeficiency virus type 1: autologous neutralizing antibody, virus load, and virus phenotype. J Pediatr. 1995;126: 865-871.
7. Lynch JB, Nduati R, Blish CA, et al. The breadth and potency of passively acquired human immunodeficiency virus type 1-specific neutralizing antibodies do not correlate with risk of infant infection. J Virol. 2011;85: 5252-5261.
8. Jayaraman P, Mohan D, Polacino P, et al. Perinatal transmission of SHIVSF162P3 in Macaca nemestrina. J Med Primatol. 2004;33: 243-250.
9. Jayaraman P, Zhu T, Misher L, et al. Evidence for persistent, occult infection in neonatal macaques following perinatal transmission of simianhuman immunodeficiency virus SF162P3. J Virol. 2007;81: 822-834.
10. Broliden K, Sievers E, Tovo PA, et al. Antibody-dependent cellular cytotoxicity and neutralizing activity in sera of HIV-1-infected mothers and their children. Clin Exp Immunol. 1993;93: 56-64.
11. Kollmann TR, Rubinstein A, Lyman WD, et al. Characterization of IgG and IgG subclass antibodies present in paired maternal and fetal serum which are directed against HIV-1 proteins. AIDS Res Hum Retroviruses. 1991;7: 847-854.
12. Mabuka J, Nduati R, Odem-Davis K, et al. HIV-specific antibodies capable of ADCC are common in breast milk and are associated with reduced risk of transmission in women with high viral loads. PLoS Pathog. 2012; 8:e1002739.
13. Wu X, Parast AB, Richardson BA, et al. Neutralization escape variants of human immunodeficiency virus type 1 are transmitted from mother to infant. J Virol. 2006;80: 835-844.
14. Neilson JR, John GC, Carr JK, et al. Subtypes of human immunodeficiency virus type 1 and disease stage among women in Nairobi, Kenya. J Virol. 1999;73: 4393-4403.
15. Euler Z, Schuitemaker H. Cross-reactive broadly neutralizing antibodies: timing is everything. Front Immunol. 2012;3: 215.